Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Zander

Showing results (131-140 of 225) with videos related to

Pageof 23
Sort By:
Annals of Hematology|August 6, 1998
Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF aloneN Kröger, W Zeller, H T Hassan, et al.
Journal of Hematotherapy & Stem Cell Research|May 3, 2000
Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cellsW Zeller, N Kröger, J Berger, et al.
British Journal of Cancer|February 1, 1981
Human myeloid leukaemic cell interactions in vitro with normal myeloid coloniesG Spitzer, D S Verma, M Beran, et al.
Leukemia|December 13, 2003
Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myelomaF Ayuk, A Shimoni, A Nagler, et al.
Blood Cancer Journal|January 14, 2014
Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell linesB C Valdez, A R Zander, G Song, et al.
Bone Marrow Transplantation|April 21, 2001
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patientsN Kröger, T Zabelina, W Krüger, et al.
Transplantation|March 1, 1984
High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adultsM D Kanojia, A A Anagnostou, A R Zander, et al.
Cancer|March 15, 1987
High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemiaA R Zander, S Culbert, S Jagannath, et al.
Annals of Internal Medicine|February 1, 1986
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's diseaseS Jagannath, K A Dicke, J O Armitage, et al.
Cancer|January 15, 1992
Second bone marrow transplants for relapsed leukemiaJ A Spinolo, J C Yau, K A Dicke, et al.
Pageof 23

Showing results (131-140 of 225) with videos related to

Sort By:
Pageof 23
Annals of Hematology|August 6, 1998
Successful mobilization of peripheral blood stem cells in heavily pretreated myeloma patients with G-CSF aloneN Kröger, W Zeller, H T Hassan, et al.
Journal of Hematotherapy & Stem Cell Research|May 3, 2000
Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cellsW Zeller, N Kröger, J Berger, et al.
British Journal of Cancer|February 1, 1981
Human myeloid leukaemic cell interactions in vitro with normal myeloid coloniesG Spitzer, D S Verma, M Beran, et al.
Leukemia|December 13, 2003
Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myelomaF Ayuk, A Shimoni, A Nagler, et al.
Blood Cancer Journal|January 14, 2014
Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell linesB C Valdez, A R Zander, G Song, et al.
Bone Marrow Transplantation|April 21, 2001
Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patientsN Kröger, T Zabelina, W Krüger, et al.
Transplantation|March 1, 1984
High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adultsM D Kanojia, A A Anagnostou, A R Zander, et al.
Cancer|March 15, 1987
High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemiaA R Zander, S Culbert, S Jagannath, et al.
Annals of Internal Medicine|February 1, 1986
High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's diseaseS Jagannath, K A Dicke, J O Armitage, et al.
Cancer|January 15, 1992
Second bone marrow transplants for relapsed leukemiaJ A Spinolo, J C Yau, K A Dicke, et al.
Pageof 23